Bringing Groundbreaking Treatments to Patients with Psychiatric and Neurodegenerative Diseases
Unleashing unique propepties and biological effects of Noble gases for treatment of PTSD, Autism, Dementia
Combining revolutionary portable inhalation device with a safe therapeutic
Accelerated pathway of clinical development
Nobilis Therapeutics is developing proprietary inhalation-based therapeutics using controlled self-administration of inert gases to address unmet medical need in the treatment of psychiatric and neurodegenerative diseases.
By leveraging data on more than 500 patients successfully treated for conditions ranging from panic disorder to autoimmune diseases, Nobilis has coupled its patent pending gas mixtures with a proprietary inhalational device to offer reproducible, standardized, and controlled patient exposure. The Company is currently advancing its technologies into human clinical trials.